Bergeron E - Search Results

1

Marquis ME, Lord E, Bergeron E, Drevelle O, Park H, Cabana F, Senta H, Faucheux N. Marquis ME, et al. Among authors: bergeron e. Front Biosci (Landmark Ed). 2009 Jan 1;14(3):1023-67. doi: 10.2741/3293. Front Biosci (Landmark Ed). 2009. PMID: 19273115 Free article. Review.

2

Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9.

Marquis ME, Lord E, Bergeron E, Bourgoin L, Faucheux N. Marquis ME, et al. Among authors: bergeron e. Biomaterials. 2008 Mar;29(8):1005-16. doi: 10.1016/j.biomaterials.2007.10.047. Epub 2007 Nov 26. Biomaterials. 2008. PMID: 18023475

3

Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9.

Bergeron E, Senta H, Mailloux A, Park H, Lord E, Faucheux N. Bergeron E, et al. Tissue Eng Part A. 2009 Nov;15(11):3341-9. doi: 10.1089/ten.TEA.2009.0189. Tissue Eng Part A. 2009. PMID: 19388833

4

Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts.

Drevelle O, Bergeron E, Senta H, Lauzon MA, Roux S, Grenier G, Faucheux N. Drevelle O, et al. Among authors: bergeron e. Biomaterials. 2010 Sep;31(25):6468-76. doi: 10.1016/j.biomaterials.2010.05.010. Epub 2010 Jun 9. Biomaterials. 2010. PMID: 20542561

5

Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways.

Park H, Bergeron E, Senta H, Guillemette K, Beauvais S, Blouin R, Sirois J, Faucheux N. Park H, et al. Among authors: bergeron e. Biochem Biophys Res Commun. 2010 Aug 27;399(3):446-51. doi: 10.1016/j.bbrc.2010.07.114. Epub 2010 Aug 3. Biochem Biophys Res Commun. 2010. PMID: 20678472

6

Bone repair: new developments in growth factor delivery systems and their mathematical modeling.

Lauzon MA, Bergeron E, Marcos B, Faucheux N. Lauzon MA, et al. Among authors: bergeron e. J Control Release. 2012 Sep 28;162(3):502-20. doi: 10.1016/j.jconrel.2012.07.041. Epub 2012 Aug 6. J Control Release. 2012. PMID: 22889715 Review.

7

Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9.

Park H, Drevelle O, Daviau A, Senta H, Bergeron E, Faucheux N. Park H, et al. Among authors: bergeron e. Anticancer Drugs. 2013 Mar;24(3):278-90. doi: 10.1097/CAD.0b013e32835cbde7. Anticancer Drugs. 2013. PMID: 23262982

8

Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres.

Bergeron E, Marquis ME, Chrétien I, Faucheux N. Bergeron E, et al. J Mater Sci Mater Med. 2007 Feb;18(2):255-63. doi: 10.1007/s10856-006-0687-4. J Mater Sci Mater Med. 2007. PMID: 17323156

9

Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations.

Senta H, Park H, Bergeron E, Drevelle O, Fong D, Leblanc E, Cabana F, Roux S, Grenier G, Faucheux N. Senta H, et al. Among authors: bergeron e. Cytokine Growth Factor Rev. 2009 Jun;20(3):213-22. doi: 10.1016/j.cytogfr.2009.05.006. Epub 2009 Jun 2. Cytokine Growth Factor Rev. 2009. PMID: 19493693 Review.

10

Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes.

Lord E, Bergeron E, Senta H, Park H, Faucheux N. Lord E, et al. Among authors: bergeron e. Growth Factors. 2010 Jun;28(3):149-56. doi: 10.3109/08977190903512610. Growth Factors. 2010. PMID: 20102315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters